Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
View Older Stories
-
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
-
Second Sight Medical (EYES) Tops Q4 EPS by 2c
-
Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results
-
Second Sight Medical (EYES) Reports In-Line Q3 EPS
-
Second Sight Reports Third Quarter 2019 Financial Results
-
Second Sight Reports Second Quarter 2019 Financial Results
-
Second Sight Medical (EYES) Announces Researchers Present Latest Positive Results of Orion Visual Cortical Prosthesis Feasibility Study
-
Researchers Present Latest Positive Results of Second Sight’s Orion Visual Cortical Prosthesis Feasibility Study
-
Second Sight Reports First Quarter 2019 Financial Results
-
Second Sight Medical (EYES) to Accelerate Development of Orion Visual Cortical Prosthesis System
-
Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System
-
Second Sight Medical (EYES) PT Lowered to $2.50 at H.C. Wainwright
-
Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results
-
Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call
-
Second Sight Medical Products, Inc. Announces Completion of Rights Offering
-
Second Sight Medical (EYES) Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Medical (EYES) Sees FY Revenue of $6.5-$6.9 million
-
Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date
-
Second Sight Reports Fourth Quarter 2018 Business Update
-
Second Sight Reports Fourth Quarter 2018 Business Update
-
Second Sight to Present at Digital Medicine and Medtech Showcase 2019
-
Second Sight to Present at Digital Medicine and Medtech Showcase 2019
-
Second Sight Medical (EYES) Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th
-
Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th
-
Second Sight Reports Third Quarter 2018 Financial Results
-
Second Sight Reports Third Quarter 2018 Financial Results
-
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
-
Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System
-
Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call
-
Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Medical (EYES) Secures $1.8M Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development
-
Second Sight Appoints Pat Ryan Chief Operating Officer
-
Second Sight to Present at Investor Conferences in September
-
Second Sight Medical (EYES) Completes $5M Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight Reports Second Quarter 2018 Financial Results
-
Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call
-
Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference
-
Second Sight Reports First Quarter 2018 Financial Results
-
Second Sight Medical (EYES) Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman
-
Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors
-
Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call
-
Second Sight Medical (EYES) Announces Dr. Robert Greenberg's Resignation from Board of Directors
-
Second Sight Announces Dr. Robert Greenberg’s Resignation from Board of Directors and as an Officer of the Company

